Stratec SE/€SBS
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Stratec SE
STRATEC SE, headquartered in Birkenfeld, Germany, specializes in designing and manufacturing fully automated analyzer systems, software, and smart consumables for the in-vitro diagnostics and life sciences sectors. Founded in 1979, the company operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment focuses on automated analyzer systems for clinical diagnostics and biotechnology clients; the Diatron segment offers systems and consumables for low-throughput hematology and clinical chemistry applications; and the Smart Consumables segment develops polymer-based consumables for diagnostics and medical applications. STRATEC primarily serves as an original equipment manufacturer (OEM), collaborating with diagnostic companies to develop products marketed under their brands. The company's global presence includes facilities in Switzerland, the United States, Romania, Hungary, Austria, and China. Its strategic positioning is reinforced by long-term partnerships with leading in-vitro diagnostics companies and a comprehensive technology portfolio that spans the entire value chain, from design and development to regulatory approval and production. (,)
- Ticker
- €SBS
- Sector
- Health
- Primary listing
- XETRA
- Employees
- 1,395
- Headquarters
- Birkenfeld, Germany
- Website
- www.stratec.com
Stratec SE Metrics
BasicAdvanced
€251m
-
-€0.28
0.80
€0.60
2.93%
Price and volume
Market cap
€251m
Beta
0.8
52-week high
€32.90
52-week low
€16.36
Average daily volume
8.1k
Dividend rate
€0.60
Financial strength
Current ratio
4.332
Quick ratio
1.788
Long term debt to equity
43.121
Total debt to equity
49.399
Interest coverage (TTM)
3.36%
Profitability
EBITDA (TTM)
24.878
Gross margin (TTM)
23.93%
Net profit margin (TTM)
-1.39%
Operating margin (TTM)
5.51%
Effective tax rate (TTM)
296.02%
Revenue per employee (TTM)
€170,000
Management effectiveness
Return on equity (TTM)
-1.42%
Valuation
Price to revenue (TTM)
1.019
Price to book
1.06
Price to tangible book (TTM)
1.96
Price to free cash flow (TTM)
24.22
Free cash flow yield (TTM)
4.13%
Free cash flow per share (TTM)
0.844
Dividend yield (TTM)
2.93%
Forward dividend yield
2.93%
Growth
Revenue change (TTM)
-8.68%
Earnings per share change (TTM)
-120.00%
3-year revenue growth (CAGR)
-2.07%
10-year revenue growth (CAGR)
5.44%
3-year earnings per share growth (CAGR)
-43.94%
10-year earnings per share growth (CAGR)
-16.70%
3-year dividend per share growth (CAGR)
-14.80%
10-year dividend per share growth (CAGR)
-2.21%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.